Wednesday, May 25, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Exploring the kinetics of SARS-CoV-2 Marseille-4 variant

by Medical Finance
in Coronavirus
Study: The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Black Queen rule. Image Credit: Lightspring/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

In a recent study posted to the medRxiv* preprint server, researchers determined the nature and dynamics of mutations associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) French Marseille-4 variant during 10 months from its onset.

Study: The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Black Queen rule. Image Credit: Lightspring/ShutterstockStudy: The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Black Queen rule. Image Credit: Lightspring/Shutterstock


The study concluded that the heterogenicity associated with a SARS-CoV-2 lineage can possibly predict the end of an outbreak.

Background

The characteristics of mutations associated with the SARS-CoV-2 variants leading to subsequent waves of the current coronavirus disease 2019 (COVID-19) pandemic are complex. The extinction of epidemics is linked to the development of herd immunity, decrease in viral load, and the implementation of therapeutic interventions such as vaccination. Moreover, sufficient data regarding factors and mechanisms associated with the emergence, transmission, and extinction of SARS-CoV-2 variants are not yet available.

About the study

In the current study, the researchers determined the kinetics of a new SARS-CoV-2 variant, called Marseille-4, identified from minks at IHU Méditerranée Infection, Marseille, France, in July 2020. The Marseille-4 variant has 20 mutations, with 13 specific mutations compared to the Wuhan-Hu-1 isolate and one among the seven non-synonymous mutations in the spike (S) glycoprotein region.

The study participants had the SARS-CoV-2 Marseille-4 variant infection and their clinical and epidemiological data were collected from the Assistance Publique-Hôpitaux de Marseille (APHM) information system.

The researchers investigated the epidemiological origin and characteristics of the Marseille-4 variant. Genetic data through 10 months from the origin to the extinction of this variant in April 2021 gathered via extensive SARS-CoV-2 genomic surveillance was analyzed using next-generation sequencing. Similarly, the 7,453 genomes of Marseille-4 obtained by next-generation sequencing were classified into lineages and subvariants. The truncated and untruncated forms of ORF8 protein were analyzed by generating a structural ORF8 protein model from the PDB 7JTL file.

The emergence, transmission, and disappearance of the SARS-CoV-2 Marseille-4 variant  were determined using these gathered data.

Results

Two subvariants of the SARS-CoV-2 Marseille-4 variant were identified in the study, namely Marseille-4A with 22 lineages from 50 genomes and Marseille-4B. During the study period, 9,616 cases associated with the Marseille-4 infection were identified using specific quantitative polymerase chain reaction (qPCR).

The average lifetime of these two variants was 4.1±1.4 months and during this period, around 4.1±2.6 mutations had developed. The growth rate was 0.010 to 0.173 in Marseille-4A.17 and Marseille-4A.15, respectively, and the average value of the growth rate was 0.079±0.045. All lineages showed a gamma distribution and were associated with the inactivation of ORF7a or ORF7b genes.

The mutations at unpredicted sites led to a new outbreak, and the accumulation of further mutations led to an increase in heterogenicity, diversity, and extinction of all lineages. None of the mutations were predicted to be probably associated with higher transmissibility, apart from those mutations in the S region.

Marseille-4B emerged after the extinction of all Marseille-4A lineages and its ORF8 gene was inhibited by a stop codon. Further, this subvariant was linked to a high number of SARS-CoV-2-associated hospitalizations and mortality, indicating that ORF8 was a non-virulence gene.

Structural analysis of the truncated form of the ORF8 gene confirmed that stop codon-induced large deletions resulted in a distinct protein that does not share any structural resemblance with the original ORF8 dimer. The average detection time for Marseille-4 lineages was around four months.

Conclusions

The study findings characterized the emergence, transmission, and vanishing of the Marseille-4 variant. The study reported heterogeneity of growth rate for various Marseille-4 subvariants and lineages and indicated that the heterogeneity associated with the SARS-CoV-2 lineage might predict the extinction of the outbreak.

Moreover, the finding suggested that SARS-CoV-2 follows the Black Queen hypothesis, stating that the loss of a gene confers a substantial advantage to the organism when the function of the gene can be dispensable.

The inhibition of the Marseille-4 genes suggested that SARS-CoV-2 originated from a distinct animal reservoir, and the ORF8 and ORF7a/b genes were not necessary to function in humans, pangolins, and minks and may be inhibited in them. The data regarding the inhibition of the ORF8 gene was in line with previous reports on several mink lineages and the Alpha variant.

Overall, it was concluded that the accumulation of beneficial mutations led to an increase in viral fitness, whereas non-beneficial mutations are associated with low viral fitness, transmissibility, and extinction of the lineage.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Post-Acute COVID-19 Syndrome (PACS) in Adults. Image Credit: Josie Elias/Shutterstock

Study explores long COVID in adults

by Medical Finance
May 24, 2022
0

A recent study published by Public Health Ontario reviewed post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS) in the adult population. Study:...

Study: Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective. Image Credit: CROCOTHERY/Shutterstock

Bacteria-mediated oral delivery of viral replicon-based mRNA vaccines

by Medical Finance
May 25, 2022
0

In a recently published article in Frontiers in Immunology, scientists have discussed the possibilities of developing oral replicon-based mRNA vaccines...

Small cluster of neurons in the brain stem found to coordinate vocalization with breathing

Over a third vaccinated-but-unboosted adults have reservations about vaccinating children

by Medical Finance
May 24, 2022
0

While the vast majority of U.S. adults who are fully vaccinated and boosted against Covid-19 would be likely to recommend...

Study: Would New SARS-CoV-2 Variants Change the War against COVID-19? Image Credit: eamesBot/Shutterstock

reinfection, vaccines, and herd immunity

by Medical Finance
May 24, 2022
0

Different technological platforms are being used to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative pathogen...

Study: Promising efficacy of following a third dose of mRNA SARS-CoV-2 vaccination in patients treated with anti-CD20 antibody who failed 2-dose vaccination. Image Credit: No-Mad/Shutterstock

Evaluating a third SARS-CoV-2 mRNA vaccine in anti-CD20-treated patients

by Medical Finance
May 24, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers assessed the efficacy of a third dose of coronavirus...

Study: Understanding Definitions and Reporting of Deaths Attributed to COVID-19 in the UK – Evidence from FOI Requests. Image Credit: Terelyuk/Shutterstock

Exploring definitions related to COVID-19 infection and deaths

by Medical Finance
May 24, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers assessed the definitions and reports of coronavirus disease 2019...

Next Post
UniSA scientists make a surprising discovery in the origins of antibiotic-resistant gene

UniSA scientists make a surprising discovery in the origins of antibiotic-resistant gene

Study: Forecast of omicron wave time evolution. Image Credit: Dmitry Demidovich/Shutterstock

Forecasting the temporal evolution of Omicron infections

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Image Credit: Prostock-studio/Shutterstock
    COVID-19 vaccination during pregnancy not associated with any observable birth defects on ultrasound
  • Study: Potent Neutralizing Activity of Polyclonal Equine Antibodies against Omicron SARS-CoV-2. Image Credit: SergeyBitos / Shutterstock.com
    Encouraging in vitro results with SARS-CoV-2-spike-specific polyclonal antibody fragments
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply